Company intelligence / Profile preview
China Shineway Pharmaceutical Group
- Ownership
- Private
- Employees
- ~3220
- Development stage
- Other
Overview
The company has a broad commercial portfolio of modernized traditional Chinese medicines with several exclusive products. It conducts ongoing clinical trials for new TCM drugs/formulations, including Phase III studies for new products such as Sechang Zhixie Powder for pediatric acute diarrhea.
- Therapeutic areas
- NeurologyWomen's HealthPulmonologyInfectious DiseasesGastroenterologyOncologyRheumatologyCardiovascular
- Modalities
- Small molecule (herbal extracts, TCM compounds)Biologic (injection products derived from natural sources)Granule-based therapy (TCM formula granules)
- Industry
- Biotech
Drug pipeline
11 assets10 more assets in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on China Shineway Pharmaceutical Group.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on China Shineway Pharmaceutical Group.